ARCHIVES

In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel

This article is from The Cancer Letter archive.

Vol. 17 No. 48 | December 13, 1991

Download PDF Visit The Full Archive

Related Articles

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI

September 13, 1985

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999